Bjarne Kristian Aaslie Hansen

Professor, 50%

Show author(s) (2021). Treatment Adherence as Predictor of Outcome in Concentrated Exposure Treatment for Obsessive-Compulsive Disorder. Frontiers in Psychiatry. 1-8.
Show author(s) (2021). Screening for obsessive-compulsive symptoms: Validation of the Dimensional Obsessive-Compulsive Scale - English and German Short Forms. Journal of Obsessive-Compulsive and Related Disorders.
Show author(s) (2021). Longitudinal changes in neurometabolite concentrations in the dorsal anterior cingulate cortex after concentrated exposure therapy for obsessive-compulsive disorder. Journal of Affective Disorders. 344-352.
Show author(s) (2021). Does Concentrated Exposure Treatment for Obsessive-Compulsive Disorder Improve Insomnia Symptoms? Results From a Randomized Controlled Trial. Frontiers in Psychiatry. 1-8.
Show author(s) (2021). Disentangling Within- and Between-Person Effects During Response Inhibition in Obsessive-Compulsive Disorder. Frontiers in Psychiatry. 1-10.
Show author(s) (2021). Diffusion Tensor Imaging Before and 3 Months After Concentrated Exposure Response Prevention in Obsessive-Compulsive Disorder. Frontiers in Psychiatry. 1-11.

Show author(s) (2020). The Bergen 4-Day Treatment (B4DT) for Obsessive-Compulsive Disorder: Outcomes for Patients Treated After Initial Waiting List or Self-Help Intervention. Frontiers in Psychology. 1-9.
Show author(s) (2020). Stable inhibition-related inferior frontal hypoactivation and fronto-limbic hyperconnectivity in obsessive–compulsive disorder after concentrated exposure therapy. NeuroImage: Clinical. 1-8.
Show author(s) (2020). Effects of Bergen 4-day treatment on resting-state graph features in obsessive-compulsive disorder. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. 1-10.
Show author(s) (2020). Effect of D-Cycloserine on the Effect of Concentrated Exposure and Response Prevention in Difficult-to-Treat Obsessive-Compulsive Disorder: A Randomized Clinical Trial. JAMA Network Open. 1-13.